| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |